ASX News
Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals
HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study.
Market Cap $39.29M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| NMT | General Neometals related news | 18:06 | 4.8K | 2.7M | |||
|
|||||||
| NMT | Ann: Neometals to Exit LiB Recycling Business | 18/08/25 | 152 | 47K | |||
|
|||||||
| NMT | Ann: Barrambie High-Grade Diamond Drill Intercepts | 06/08/25 | 13 | 4.6K | |||
|
|||||||
| NMT | Ann: Change of Director's Interest Notice | 01/08/25 | 0 | 394 | |||
|
|||||||
| NMT | Ann: Notification regarding unquoted securities - NMT | 01/08/25 | 0 | 280 | |||
|
|||||||
| NMT | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 29/07/25 | 8 | 3.3K | |||
|
|||||||
| NMT | Ann: Change of Director's Interest Notice x 3 | 25/07/25 | 1 | 868 | |||
|
|||||||
| NMT | Ann: Application for quotation of securities - NMT | 24/07/25 | 0 | 435 | |||
|
|||||||
See All Discussions
Timeline
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $39.29M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.1¢ | $84.01K | 1.599M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 420063 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 158535 | 1 |
View Market Depth
| Last trade - 15.58pm 22/08/2025 (20 minute delay) ? |
|
|||||
|
Last
5.1¢ |
Change
-0.002 ( 1.92 %) |
||||
| Open | High | Low | Volume | ||
| 5.2¢ | 5.3¢ | 5.1¢ | 407974 | ||
| Last updated 15.58pm 22/08/2025 ? | |||||
| NMT (ASX) Chart |
